Teresa Woodruff, PhD, vice chair for research in the Department of Obstetrics and Gynecology and dean of the Graduate School, has been elected to the National Academy of Medicine.
Monthly Archives: October, 2018
An experimental genetic inhibitor that could stave off Alzheimer’s disease has unintended consequences, but may represent a target for future drug development, according to a recent study.
Metformin, an inexpensive diabetes drug, has been found to reduce the risk of heart attacks and strokes triggered by air pollution by reducing inflammation in the lungs that triggers clotting.
Heather Campbell, MHS, has been named vice dean for finance and administration for Northwestern University Feinberg School of Medicine.
An oral therapy called ibudilast significantly reduced the rate of brain tissue loss in patients with progressive multiple sclerosis, according to the results of a phase II trial.
Second-year medical students showcased ongoing results from their Area of Scholarly Concentration projects at a recent poster session.
Northwestern Medicine investigators are leading a Specialized Program of Research Excellence (SPORE) in brain cancer with a special emphasis on glioblastoma.
Scientists have developed soft materials that assemble and disassemble on demand, opening the door for applications including robotics, drug delivery and tissue regeneration.
Scientists have developed the first example of a bioresorbable electronic medicine: an implantable, biodegradable wireless device that speeds nerve regeneration and improves the healing of a damaged nerve.